These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Porphyria. Fasting and drugs threaten health status of porphyria patients]. Thunell S Vardfacket; 1989 Aug; 13(14):XVI-XIX. PubMed ID: 2596175 [No Abstract] [Full Text] [Related]
4. Recent progress in the biochemistry and physiology of acute intermittent porphyria. Tschudy DP Med Ann Dist Columbia; 1967 Apr; 36(4):219-23. PubMed ID: 5232850 [No Abstract] [Full Text] [Related]
5. The porphyrias: genetic and acquired aspects. Sassa S Rinsho Ketsueki; 2001 Apr; 42(4):237-41. PubMed ID: 11400290 [No Abstract] [Full Text] [Related]
13. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers]. Tasnádi G; Bor M; Pusztai A Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070 [TBL] [Abstract][Full Text] [Related]
14. Late-onset porphyrias: what are they? Sassa S; Akagi R; Nishitani C; Harigae H; Furuyama K Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):97-101. PubMed ID: 11929054 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous porphyria in alcoholic siblings. Holmes JG; Barnes HD Trans St Johns Hosp Dermatol Soc; 1965; 51(1):55-9. PubMed ID: 5831439 [No Abstract] [Full Text] [Related]
16. Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias. Solis C; Martinez-Bermejo A; Naidich TP; Kaufmann WE; Astrin KH; Bishop DF; Desnick RJ Arch Neurol; 2004 Nov; 61(11):1764-70. PubMed ID: 15534187 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart. Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245 [TBL] [Abstract][Full Text] [Related]